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Aim To investigate the changes in the venoarterial carbon-
dioxide gradient (V-a Pco2) and its prognostic value for sur-
vival of patients with severe sepsis and septic shock.
Methods The study was conducted in General Hospital 
Holy Spirit from January 2004 to December 2007 and in-
cluded 71 conveniently sampled adult patients (25 wom-
en and 46 men), who fulfilled the severe sepsis and septic 
shock criteria and were followed for a median of 8 days 
(interquartile range, 12 days). The patients were divided in 
two groups depending on whether or not they had been 
mechanically ventilated. Both groups of patients under-
went interventions with an aim to achieve hemodynamic 
stability. Mechanical ventilation was applied in respiratory 
failure. Venoarterial carbon dioxide gradient was calculated 
from the difference between the partial pressure of arterial 
CO2 and the partial pressure of mixed venous CO2, which 
was measured with a pulmonary arterial Swan-Ganz cath-
eter. The data were analyzed using Kaplan-Meier survival 
analysis, along with a calculation of the hazard ratios.
Results There was a significant difference between non-
ventilated and ventilated patients, with almost 4-fold 
greater hazard ratio for lethal outcome in ventilated pa-
tients (3.85; 95% confidence interval, 1.64-9.03). Further-
more, the pattern of changes of many other variables was 
also different in these two groups (carbon dioxide-related 
variables, variables related to acid-base status, mean arteri-
al pressure, systemic vascular resistance, lactate, body mass 
index, Acute Physiology and Chronic Health Evaluation II, 
Simplified Acute Physiology II Score, and Sepsis-related Or-
gan Failure Assessment score). Pco2 values (with a cut-off 
of 0.8 kPa) were a significant predictor of lethal outcome 
in non-ventilated patients (P = 0.015) but not in ventilated 
ones (P = 0.270).
Conclusion V-a Pco2 was a significant predictor of fatal 
outcome only in the non-ventilated group of patients. Ven-
tilated patients are more likely to be admitted with a less 
favorable clinical status, and other variables seem to have a 
more important role in their outcome.
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Although oxygen delivery (Do2) in septic shock can be el-
evated, oxygen consumption (VO2) is impaired (1). This 
could be a consequence of mitochondrial dysfunction in 
sepsis (2,3). Blood circulation is slow and consequently the 
elimination of CO2 from the tissue is slower, making the tis-
sue CO2 concentration high. Venoarterial carbon dioxide 
gradient (V-a Pco2) was calculated from the difference be-
tween the partial pressure of arterial CO2 (Paco2) and the 
partial pressure of mixed venous CO2 (PvCO2), which was 
measured with a pulmonary arterial Swan-Ganz catheter.
The venoarterial CO2 gradient (V-a Pco2) is influenced by 
two other factors: the dissociative curve of CO2 and tissue 
blood flow. The curve of CO2 dissociation from hemoglobin 
follows the so-called Haldane’s effect, in which oxygen and 
its bonding with hemoglobin allows easier release of car-
bon dioxide in lungs (4). Experimental models have shown 
that in toximia, venous hypercapnia is a more significant 
contributor to the increase in the venoarterial CO2 gradi-
ent than arterial CO2 values (4-7). Elevated V-a Pco2 has also 
been described in patients with sepsis, cardiogenic shock, 
acute myocardial infarction, and congestive heart failure, 
as well as cardiac arrest following cardiopulmonary resus-
citation and heart surgery (8-13).
In septic patients, the significance of the connection be-
tween an elevation of V-a Pco2 and the course and out-
come of the illness is not sufficiently known. It has been 
established that V-a Pco2 shows a negative exponential re-
lationship with the cardiac index (CI) (14,15). The negative 
association with CI has been observed not only in septic 
shock patients but also in postoperative patients without 
sepsis. In patients with a lethal outcome, CI was reduced, 
but V-a Pco2 was not an independent predictor of outcome 
(14,16).
The aim of this study was to investigate the changes in V-a 
Pco2 to better understand the possibilities of using it as a 
predictor of clinical outcomes in patients with severe sep-
sis and septic shock.
PaTIenTs and MeThods
This was a prospective observational study that included all 
patients admitted to the 8-bed intensive care unit of Holy 
Spirit Hospital, Zagreb, Croatia, in the period from January 
2004 to December 2007. The study protocol was approved 
by the Local Ethics Committee of the Holy Spirit Hospital. 
Standards of Good Clinical Practice (17) and the Decla-
ration of Helsinki (18) were followed. There were 189 
admitted patients with the initial diagnosis of sepsis, but 
only 114 patients satisfied the inclusion criteria of having 
severe sepsis and septic shock according to the American 
College of Chest Physicians and the Society of Critical Care 
Medicine criteria for severe sepsis and septic shock (19,20). 
Four patients were excluded because they had acute pan-
creatitis, which is initially presented as systemic inflamma-
tory response syndrome. Thus, the final study population 
consisted of 71 patients. All patients, or their legal repre-
sentatives, reviewed and signed the informed consent 
form approved by the local Ethics Committee.
Conventional hemodynamic monitoring was carried out 
using a pulmonary arterial Swan-Ganz catheter (PAC). We 
carried out PAC measurements an average of 6-8 times per 
month on critically ill patients. At the time of this study, se-
vere sepsis and septic shock were the indications for PAC 
and it was the part of “the standard of hospital care” at our 
institution. Cardiac output was determined by thermodilu-
tion using a PAC; 10 mL of 5% glucose was administered 
at room temperature 3 times over two-minute intervals 
to calculate the mean values. Oxygen delivery (Do2) was 
determined using an in-vitro analysis of arterial blood, ac-
cording to the standard formula (21). Oxygen consump-
tion (VO2) was measured according to direct and indirect 
Fick’s principles (21). The venoarterial difference in CO2 par-
tial pressure (V-a Pco2) was calculated from the difference 
between the partial pressure of arterial CO2 (Paco2) and the 
partial pressure of mixed venous CO2 (PvCO2). The limiting 
value of V-a Pco2 was set at 0.8 kPa (22). This information 
was used as a binary variable in all subsequent analyses. 
V-a Pco2 values >0.8 kPa were defined as pathological and 
V-a Pco2 values <0.8 kPa as normal.
To measure the hemodynamic variables, the oxygen and 
carbon dioxide variables and the variables related to ac-
id-base status, blood samples were taken simultaneously 
from a peripheral artery and the pulmonary artery at the 
following time points: (i) upon admission to the inten-
sive care unit; (ii) immediately after administration of the 
specific therapy (plasma expanders, vasoactive medica-
tions, and mechanical ventilation); and (iii) 6 hours after 
the beginning of monitoring. The patients were divided in 
two groups depending on whether or not they had been 
mechanically ventilated before the measurements were 
conducted: non-ventilated group (n = 31) and ventilated 
group (n = 40).
For the patients suffering from sepsis, there is still no stan-
dardized recommended scoring system. Therefore, we 
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used the APACHE II scoring system to evaluate high mor-
tality risks (23,24). Furthermore, organ failure is a main mor-
tality risk factor in critically ill patients, and it may have a 
significant impact on CO2 production. Thus we also as-
sessed our patients using the SOFA scoring system (25).
The analyses were performed to make comparisons be-
tween non-ventilated and ventilated patients and also be-
tween the survivors and non-survivors.
statistical methods
Due to the small sample size, the median and interquartile 
range (IQR) were used in the descriptive statistical analysis. 
The analytical methods included the χ2 test, Mann-Whit-
ney test, and Friedman test. The Kaplan-Meier method 
was used for survival analysis, along with the Breslow test, 
where the duration of hospitalization was used as time 
variable and lethal outcome was considered to be an out-
come variable. Correlation was investigated using Spear-
man rank test. Cox regression analysis was used as the 
multivariate method for survival analysis. All analyses were 
performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). 
Significance level was set at P < 0.05.
ResulTs
The study included 71 patients (25 women and 46 men), 
with median age of 67.0 years (IQR, 14.0 years). The origin 
of sepsis was most frequently lungs (pneumonia) in 34 
(48%) cases and the abdominal cavity in 16 (23%) cases, 
including inflamed gallbladder in 6 patients (8.5%), cholan-
gitis in 8 patients (11.3%), infected pancreatic necrosis in 2 
patients (2.8%), and urinary tract in 9 (11.7%) cases. Other 
non-abdominal sites were the cause in 8 patients (11.3%). 
In 4 patients (5.6%), the source was not established.
Using cultures from blood, urine, sputum, and wound as-
piration, we determined the cause of sepsis in 50 patients 
(70%). We obtained a total of 85 positive isolates with 3 
or more positive samples belonging to one patient. In 51 
positive isolates (60%), Gram-negative bacteria were iden-
tified and the most frequent species were Escherichia coli, 
Proteus mirabilis, and Klebsiella pneumoniae. In 26 isolates 
(31%), Gram-positive bacteria were isolated and identified; 
the most common species were Staphylococcus aureus, En-
terococcus faecalis, and Streptococcus pneumoniae.
Before Swan-Ganz catheterization and the collection of 
the first measurements, 31 of our patients (44%) did not re-
quire mechanical ventilation, while the remaining 40 (56%) 
had already been ventilated. Subsequent to pulmonary 
catheterization, another 4 patients were placed on ventila-
tion due to respiratory insufficiency.
Table 1. Comparison of clinical, hemodynamic, and blood gas 
variables in non-ventilated and ventilated patients with severe 







(n = 40) P‡
CaO2 (mL/dL)   15.5 (4.6)   15.3 (4.6)   0.842
CvO2 (mL/dL)    9.8 (4.3)    9.6 (3.3)   0.956
A-V Do2 (mL/dL)    5.7 (2.1)    5.6 (3.8)   0.877
SaO2 (%)   94.5 (6.8)   94.0 (12.8)   0.807
SvO2 (%)   61.0 (10.8)   60.5 (19.0)   0.681
PaO2 (kPa)    8.9 (2.6)    9.1 (7.5)   0.352
PvO2 (kPa)    4.3 (0.8)    5.0 (1.7)   0.061
Paco2 (kPa)    4.3 (1.2)    5.1 (2.1)   0.044
PvCO2 (kPa)    4.9 (1.3)    6.7 (4.3)   0.001
V-a Pco2 (kPa)    0.6 (0.6)    1.2 (1.9)   0.009
A pH    7.4 (0.1)    7.3 (0.3)   0.040
V pH    7.4 (0.1)    7.2 (0.3)   0.006
BMI (kg/m2)   26.5 (5.9)   27.4 (4.0) <0.001
APACHE II score   18.0 (10.0)   35.0 (11.0) <0.001
SAPS II score   45.0 (21.0)   67.0 (23.0) <0.001
SOFA score 1st day (23)   10.0 (5.0)   13.0 (3.0) <0.001
SOFA score 3rd day (23)   10.5 (5.0)   14.0 (4.0) <0.001
DO2 (mL/min/m
2)  805.1 (410.0)  848.0 (334.0)   0.293
VO2 (mL/min/m
2)  237.0 (131.0)  284.0 (227.0)   0.268
O2 ER (%)   36.0 (18.5)   34.8 (22.3)   0.315
Lactate (mmol/L)    5.7 (2.0)    6.3 (7.1)   0.016
MAP (mmHg)    81.0 (23.8)   70.5 (37.8)   0.021
HR (beat/min)  107.0 (29.3)  118.5 (28.5)   0.119
CI (L/min/m2)    2.4 (1.32)    3.0 (1.11)   0.281
CVP (cmH2O)   10.0 (5.0)    7.0 (7.0)   0.304
MPAP (mmHg)   30.5 (14.3)   25.0 (13.0)   0.955
PCWP (mmHg)    9.0 (16.0)   12.0 (9.0)   0.611
SVR (dynes.sec/m5) 1468.0 (662.8) 1275.0 (469.0)   0.030
PVR (dynes.sec/m5)  202.0 (167.5)  157.0 (106.8)   0.449
*abbreviations: Cao2 – arterial oxygen content; Cvo2 – venous oxygen 
content, a-V do2 – arterial-venous oxygen content difference; sao2 
– arterial oxygen saturation; svo2 – mixed venous saturation; Pao2 – 
partial pressure of arterial oxygen; Pvo2 – partial pressure of mixed 
venous oxygen; Paco2 – partial pressure of arterial carbon dioxide; 
PvCo2 – partial pressure of mixed venous carbon dioxide; V-a Pco2 
– venoarterial carbon dioxide gradient; a ph – arterial ph; V ph – ve-
nous ph; bMI – body mass index; do2 – oxygen delivery; Vo2 – oxygen 
consumption; o2 eR – oxygen extraction ration; MaP – mean arterial 
pressure; hR: heart rate; CI – cardiac index; CVP – central venous pres-
sure; MPaP – mean pulmonary artery pressure; PCWP – pulmonary 
capillary wedge pressure; sVR – systemic vascular resistance; PVR – 
pulmonary vascular resistance.
†Values are median (IQR).
‡Mann-Whitney test.
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Overall, the mortality rate among the included patients 
was 65%, and there was no sex difference (71.8% of men 
and 50.0% of women; χ2 = 23.77; P = 0.096); however, there 
was a significant difference in the overall mortality be-
tween the ventilated (92.3%) and non-ventilated patients 
(35.0%; χ2 = 16.89; P < 0.001). The median age of the surviv-
ing group was 61 years (IQR, 22) and of the group with fatal 
outcomes 67 years (IQR, 9). The difference between them 
was not significant (P = 0.453).
In all our patients, the median for V-a Pco2 was 0.9 kPa (IQR, 
1.0): 0.6 kPa (IQR, 0.6) in non-ventilated patients and 1.2 kPa 
(IQR 1.9) in ventilated patients (P = 0.009). In addition to 
V-a Pco2 values, we observed a number of significant dif-
ferences between non-ventilated and ventilated patients, 
especially in the variables related to CO2 pressures (Paco2, 
PvCO2), pH values (a pH, v pH), clinical variables (body mass 
index, Acute Physiology and Chronic Health Evaluation II 
score (23), Simplified Acute Physiology II Score (26), and 
Sepsis-related Organ Failure Assessment score 1st day and 
3rd day) and lactate and hemodynamic variables (mean ar-
terial pressure and systemic vascular resistance) (Table 1).
Age and sex did not significantly affect survival: however, 
a significant difference was found between patients who 
Table 2. survival in relation to age, sex, and use of mechani-





age 0.577 1.01 (0.97-1.05)
sex:
men (ref.) 1.00
women 0.519 0.76 (0.33-1.76)
use of mechanical ventilation:
yes (ref.) 1.00
no 0.002 3.85 (1.64-9.03)
*Cox regression.
Table 3. Prediction of fatal outcome in non-ventilated and 
ventilated patients with severe sepsis and septic shock*
non-ventilated 
patients (n = 31)
Ventilated
patients (n = 40)
Parameter P hR (95% CI)* P hR (95% CI)†
age 0.439 1.04 (0.95-1.13) 0.858 1.00 (0.94-1.05)
sex:
men (ref.) 1.00 1.00
women 0.617 0.58 (0.07-4.99) 0.904 0.93 (0.29-3.02)
V-a Pco2 0.015 4.33 (1.33-14.11) 0.270 1.25 (0.84-1.86)
PvCo2 0.146 0.60 (0.30-1.19) 0.946 0.99 (0.81-1.22)
*abbreviations: V-a Pco2 – venoarterial carbon dioxide gradient, PvCo2 
– partial pressure of mixed venous carbon dioxide; CI –confidence 
interval; hR – hazard ratio.
†Cox regression.
Figure 1.
Values of venoarterial carbon dioxide gradient (V-a Pco2) in relation to 
survival in the group of non-ventilated patients. dash line <0.8 kPa; solid 
line 0.8≥kPa; square – censored. breslow P = 0.002.
Figure 2.
Venoarterial carbon dioxide gradient (V-a Pco2) levels in relation to sur-
vival in the group of ventilated patients. dash line <0.8 kPa; solid line 
0.8≥kPa; square – censored. breslow P = 0.002.
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had required mechanical ventilation and those who had 
not, with hazard ratios of survival being almost 4 times 
greater in those who had not been ventilated (Table 2).
Because of the limited sample size, the variables of age and 
sex were included in the Cox regression analysis, as well as 
the two variables with the strongest bivariate correlation 
with fatal outcome: V-a Pco2 and PvCO2. The analysis was 
applied separately to the ventilated group and separately 
to the non-ventilated group. V-a Pco2 was determined to 
be the best outcome predictor, but only in the non-venti-
lated group (Table 3). We analyzed the data for a possible 
correlation between V-a Pco2 and CI, but the association 
was not significant (r = -0.21; P = 0.162).
The next step was to determine the influence of the select-
ed predictive variables on V-a Pco2. In both non-ventilated 
and ventilated patients, 0.8 kPa was taken as the cut-off 
point of V-a Pco2. Difference in survival between non-ven-
tilated and ventilated patients was significantly affected 
by the values of V-a Pco2. In the non-ventilated group, sur-
vival was significantly higher among the patients with V-a 
Pco2 values lower than 0.8 kPa (Figure 1). In the ventilated 
group, V-a Pco2 had no significant effect on survival (Figure 
2). These results indicate that V-a Pco2 does not have a pre-
dictive role in ventilated patients, while in the non-ventilat-
ed group, it is a significant predictor of fatal outcome.
dIsCussIon
This study showed the strong clinical importance of V-a 
Pco2 for prediction of fatal outcomes in non-ventilated pa-
tients but not in ventilated patients. This parameter indi-
cates the difference between partial pressure of mixed ve-
nous and arterial blood CO2 and does not exceed 0.8 kPa 
(6 mm Hg) under normal conditions (22). An increase in 
the gradient above normal values can be caused by ei-
ther an increase in partial pressure of mixed venous blood 
CO2, a reduction in the partial pressure of CO2 in arterial 
blood, or a simultaneous change in both. The venoarte-
rial gradient of CO2 is also influenced by two other factors: 
the dissociative curve of CO2 (Haldane’s effect) and tissue 
blood flow (4). The relationship between V-a Pco2 and CI 
was inverse, but it was not significant. In normoxic condi-
tions, the association between V-a Pco2 and CI is nonlin-
ear. The association between V-a Pco2 and cardiac output 
is also nonlinear: changes in cardiac output values led to 
increases in V-a Pco2 that are greater at lower values of car-
diac output than at higher values of cardiac output (27). 
Earlier research on patients with septic shock and post-
operative patients without sepsis has indicated that an in-
crease in V-a Pco2 above 6 mm Hg (0.8 kPa) precipitated 
a decrease in the CI and that the association was expo-
nential (14-16). Other studies conducted on experimental 
models of severe sepsis and septic shock (4,5,28,29) have 
mostly indicated that an increase in V-a Pco2 is associated 
with a reduction in cardiac output. However, during sep-
sis, tissue hypercapnia may develop despite a normal or 
even high CI (29). However, in patients with reduced CI, 
the index can generally be improved by supplementing 
the blood volume with colloid or crystalloid solution, plas-
ma expanders, operative procedures (30,31), or vasoactive 
medication (32).
The difference in survival between non-ventilated and 
ventilated patients is likely to be explained by a con-
founding effect due to indication, because patients with 
more severe initial clinical presentation are more likely to 
be attached to a ventilator. Indeed, this study indicates a 
number of changes in ventilated patients; they presented 
higher values for variables related to CO2 (PvCO2, Paco2, 
V-a Pco2, lactate) and for clinical variables (body mas in-
dex, APACHE II score, Simplified Acute Physiology Score, 
SOFA 1st and 3rd day score), lower values for variables 
related to acid-base status (pH, v pH) and hemodynamic 
variables (mean arterial pressure and systemic vascular 
resistance). These numerous differences further support 
the assertion that these two groups of patients experi-
ence vastly different clinical courses. Ventilated patients 
had significantly higher values of APACHE II score and 
SOFA 1st and 3rd day score.
We found a significantly greater survival rate among the 
patients in the non-ventilated group with V-a Pco2 lower 
than 0.8 kPa. It has been shown that V-a Pco2 exceeding 0.8 
kPa is associated with numerous hemodynamic changes 
and with overall survival but that its predictive value is me-
diocre and that it is not an independent predictor of out-
come (14,16,28). The difference from previously published 
studies could partly be explained by the differences in the 
inclusion criteria, as the patients who participated in previ-
ous studies were not divided according to ventilation (16), 
thus preventing a more detailed analysis and understand-
ing of clinically important metabolic changes (29).
Several oxygen-based clinical parameters have been pro-
posed as possible predictors of sepsis outcome. An ad-
ditional process that can exacerbate sepsis is general 
adrenergic stimulation brought on by a reduction in 
blood flow. This process increases oxygen consump-
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tion, which worsens the situation on the periphery. How-
ever, the accumulating CO2 inhibits the alpha-adrenergic 
receptors; this effect conserves oxygen but can also nega-
tively impact flow. As a result of the redistribution of flow 
that begins to appear at this stage of sepsis, the splanchnic 
circulation is seriously affected, potentially leading to mul-
tiple organ dysfunctions and fatal outcome (33). Compro-
mised pulmonary function could be an additional source 
of lactates in patients with acute lung damage (34), which 
further contributes to the dysfunction of multiple organs 
and increases the chances of a fatal outcome (33,35,36). 
Furthermore, during mechanical ventilation, fraction of in-
spired oxygen affects the alveolar-arterial oxygen tension 
difference. This effect is explained by a decrease in hypoxic 
pulmonary vasoconstriction, which normally acts to redi-
rect blood flow away from poorly ventilated lung regions. 
Breathing that does not participate in gas exchange is 
characterized by a disproportion of ventilation perfusion 
(mismatch) ratio, V/Q ratio >1. An increase of dead space is 
produced by reduction of the Pao2 and Paco2 elevation. Re-
tention of CO2 in the blood occurs when VD/VT rises above 
50% (37).
None of the oxygen variables was a good indicator of the 
outcome in our population of patients with severe sepsis 
or septic shock. Earlier studies have also failed to deter-
mine whether oxygen-related variables were useful in out-
come prediction in patients with sepsis (38-42). According-
ly, a significant improvement in outcome in severe sepsis 
and septic shock is associated with achieving a target of 
≥70% central venous oxygen saturation during the first 6 
hours after admission (43). Despite its effects on systemic 
circulation and elevated supply and consumption of oxy-
gen, sepsis is often accompanied by circulatory failure and 
multiple organ dysfunctions (39,41). Some recent studies 
support the use of monitoring-driven treatment protocols 
and argue against the concept of normal and supernormal 
cardiac output values, instead classifying the values into 
adequate or inadequate to meet the metabolic demands 
(44). Ultimately, one of the major changes in sepsis is a loss 
of microcirculatory autoregulation – vasoplegia (45). Our 
results suggest that cardiac output may not be the most 
reliable predictor of sepsis outcome.
The main limitation of this study was the small sample size. 
The study was based on a pre-defined set of study param-
eters, which might not have reflected the true nature of 
general changes observed in sepsis. In addition, a PAC, 
which is quite an invasive method, was used to monitor 
hemodynamics and V-a Pco2.
Despite the limitations of the study, our data suggest that 
venoarterial gradient Pco2 might be used as a fatal out-
come predictor in non-ventilated patients with severe sep-
sis and septic shock but not in the group of ventilated pa-
tients. Further studies on a larger number of patients are 
needed to confirm the reliability of this predictor.
note
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